Meiyanti Meiyanti

Dr. Meiyanti Meiyanti

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 August 2024 in Narra J
Verified
Journal Article
Open access
PDF file
MMMeiyanti Meiyanti
Meiyanti Meiyanti
ABAdang Bachtiar
Adang Bachtiar
RKRina K. Kusumaratna
Rina K. Kusumaratna
AAArifah Alfiyyah
Arifah Alfiyyah
MMMachrumnizar Machrumnizar
Machrumnizar Machrumnizar
PPPusparini Pusparini
Pusparini Pusparini
Successfully treating tuberculosis (TB) could significantly help reduce its spread. The aim of this study was to identify factors associated with successful TB treatment. A retrospective study was conducted in West Nusa Tenggara, Indonesia, using data from the National TB Information System (SITB) covering patients from January 1 to December 31, 2022. Patients were classified into two groups: those with successful treatment outcomes (cured or completed treatment) and those with unsuccessful outcomes (including treatment failure, loss to follow-up, or death). Univariate and multivariate logistic regression analyses were performed to identify factors associated with treatment outcomes, providing odds ratios (OR) and adjusted odds ratios (aOR) with 95% confidence intervals (CIs). A total of 2,225 TB patients (1,382 males and 843 females) were included in the study. Of these, 2,048 (92.1%) achieved successful treatment outcomes. Univariate analysis indicated that older age (OR: 0.47; 95%CI: 0.28–0.78) and a high number of AFB in sputum smears (OR: 0.23; 95%CI: 0.09–0.66) were associated with a higher likelihood of unsuccessful TB treatment. In contrast, having no HIV infection (OR: 13.44; 95%CI: 6.22–29.08), clinical TB cases (diagnosed clinically rather than bacteriologically) (OR: 1.50; 95%CI: 1.04–2.20) and longer duration of TB treatments were associated with successful treatment outcomes. Multivariate analysis suggested that the TB treatment durations of 4–6 months (aOR: 1256.95; 95%CI: 431.89–3658.19) and 7–12 months (aOR: 575.5; 95%CI: 99.1–3342.06) were associated with a significantly higher likelihood of success compared to durations of 0–3 months. In conclusion, this study highlights that a minimum treatment duration of three months was crucial for increasing the likelihood of successful TB treatment. These findings emphasize the importance of comprehensive support programs to ensure adherence to treatment guidelines and improve outcomes.

15 July 2023 in Journal of Drug Delivery and Therapeutics
Verified
Journal Article
Open access
PDF file
MMMeiyanti Meiyanti
Meiyanti Meiyanti
YOYohana
Yohana
EMEveline Margo
Eveline Margo
JCJuni Chudri
Juni Chudri
PUPusparini
Pusparini
MFMeutia Atika Faradilla
Meutia Atika Faradilla
Aging is a progressive process caused by a physiological decline in body functions. It is known that several factors can accelerate aging, namely age, lifestyle, oxidative stress, lipid peroxidation, and mitochondrial damage. Various pollutants such as cigarette smoke, motor vehicle fumes, industrial waste, and exposure to sunlight / ultraviolet light will form free radicals. Malondialdehyde (MDA) level is one of the indicators used to measure oxidative stress. Increased MDA levels are found in various degenerative diseases. This study aims to determine plasma MDA levels in the age group of 40 years and over and factors that can affect plasma MDA levels. This study was a cross-sectional study by including 42 subjects. Data collection was carried out using a questionnaire to obtain subject demographic data and physical activity, as well as physical examinations complemented by laboratory examinations and MDA levels. The mean age of the subjects was 52.7 years, and most of the 32 (76.2%) subjects were categorized as obese and had high activity. Pearson correlation test obtained body mass index statistically significantly correlated with plasma MDA levels with a value of p = 0.039, as well as physical activity statistically significantly correlated with a negative correlation, with a value of r = -0.26 and p = 0.043. Conclusion Body mass index and activity are significantly correlated with plasma MDA levels. Keywords: malondialdehyde, stress, oxidative, radicals

15 January 2022 in Journal of Drug Delivery and Therapeutics
Verified
Journal Article
Open access
PDF file
MMMeiyanti Meiyanti
Meiyanti Meiyanti
LMLyfanni Fiesa Mulia
Lyfanni Fiesa Mulia
PMPusparini Mulia
Pusparini Mulia
The long-term use of some drugs causes side effects in the form of elevated liver enzyme levels. Meanwhile, antipsychotic drug therapy in people with mental disorders induces liver injury which leads to an elevation in serum glutamic oxaloacetic and pyruvic transaminases. Therefore, this study aims to analyze the relationship between the uses of antipsychotic drugs with elevated liver enzymes in people with mental disorders. This observational study used a cross-sectional design that included 69 people with mental disorders. The respondents were selected based on consecutive non-random sampling, while the data were collected using a questionnaire to obtain the universal characteristics of the subjects, therapy duration, and antipsychotic type, as well as an examination of AST and ALT levels using the ultraviolet test method. Furthermore, data analysis was conducted using the chi-Square test with a significance level of p<0.05. The results showed that thirty-two among the respondents or 46.4% used atypical antipsychotics, while 37 or 73.0% received the drugs for 1-6 months. In the subjects receiving typical antipsychotics, 10 or 55.6% had a significant elevation in liver enzymes compared to others receiving atypical antipsychotics namely 6 (18.8%) or a combination of both drugs namely 6 (31.6%). Therefore, the type of antipsychotic used in therapy has a significant relationship with elevated liver enzymes in people with mental disorders (p=0.028). Keywords: antipsychotics, drugs, elevated

1 July 2025 in BMJ Public Health
Verified
Journal Article
Open access
MMMachrumnizar Machrumnizar
Machrumnizar Machrumnizar
TETris Eryando
Tris Eryando
ABAdang Bachtiar
Adang Bachtiar
RKRina Kurniasri Kusumaratna
Rina Kurniasri Kusumaratna
MMMeiyanti Meiyanti
Meiyanti Meiyanti
AAArifah Alfiyyah
Arifah Alfiyyah
Introduction: Tuberculosis (TB) and HIV co-infection remain a significant public health challenge in Indonesia. Therefore, this study aims to identify the determinants and epidemiological characteristics of TB-HIV co-infection using data from the 2023 national TB registry. Methods: The study procedures were carried out using a cross-sectional design, analysing univariate, bivariate and multivariate associations between TB-HIV coinfection status and demographic, clinical and health service factors among patients with TB. Results: Among 22 698 patients with TB, 94.8% were HIV negative, with a predominance of males (58.8%) and adults aged 30–59 years (49.8%). The majority of the patients were treated in healthcare facilities located in Western Indonesia, had pulmonary TB (93.8%), bacteriological diagnosis (55.5%) and achieved a cure (85.9%), while the remaining 14.1% included patients who died, were lost to follow-up, or had incomplete treatment outcomes. The most common nutritional status among patients was normal nutritional status (44.4%). In the multivariate analysis, clinical diagnosis remained the strongest predictor of TB-HIV co-infection (OR 2.446; 95% CI 2.154 to 2.778; p<0.001). Other significant predictors included male sex (OR 2.096; 95% CI 1.835 to 2.395), extrapulmonary TB (OR 1.337; 95% CI 1.075 to 1.662) and undernourished status, which showed lower odds of TB-HIV co-infection compared with overweight or obese patients (OR 0.809; 95% CI 0.676 to 0.967). Conclusions: This study highlights TB-HIV co-infection as the primary outcome, emphasising the role of demographic, clinical, nutritional and regional disparities in influencing co-infection risks. The findings underscore the need for integrated TB-HIV diagnostic and management strategies, including nutritional support and targeted interventions focusing on high-risk populations and health service accessibility to strengthen early detection and treatment outcomes.

30 April 2020 in Global Medical & Health Communication (GMHC)
Verified
Journal Article
Open access
PDF file
MMMeiyanti Meiyanti
Meiyanti Meiyanti
EMEveline Margo
Eveline Margo
JCJuni Chudri
Juni Chudri
Effect of Phaleria macrocarpa (Scheff.) Boerl Dry Extract to the Level of Malondialdehyde

29 August 2021 in Global Medical & Health Communication (GMHC)
Verified
Journal Article
Open access
PDF file
NSNurbaiti Annisaa Soegiharto
Nurbaiti Annisaa Soegiharto
MMMeiyanti Meiyanti
Meiyanti Meiyanti
Growth disorders in short stature are often found in patients with β-thalassemia major. It is caused by several factors such as hypoxia, hemosiderosis, deficiency of nutritional intake, and micronutrient. Disorder in growth will affect the patient's quality of life. This study aims to determine the prevalence of growth disorders and analyze the factors associated with thalassemia child growth disorders. This study used an observational analytic study with a cross-sectional design on 167 patients with β-thalassemia major at the Palang Merah Indonesia Hospital, Bogor, West Java, in October–December 2018. Data was collected using a transfusion compliance questionnaire and the Morisky Medication Adherence Scale (MMAS-8), while growth was assessed using the CDC 2000 height/age curve. Data analysis used SPSS for Windows version 21.0. Of 167 subjects, 86 subjects (51.5%) were not adherent to transfusion, 97 subjects (58.1%) had low consumption of chelation iron, and 146 subjects (87.4%) had growth problems. The results of bivariate data analysis using the chi-square test for transfusion compliance and parental education on growth obtained p=0.000 and p=0.032. Likewise, for compliance with iron chelation consumption and parents' income to growth, the p value=0.000 was obtained. It was concluded that the prevalence of growth disorders was 87.4%, and there was a relationship between transfusion compliance, parental education level, parents' income, and compliance with iron chelation consumption on growth disorders in thalassemia children. FAKTOR-FAKTOR YANG BERHUBUNGAN DENGAN GANGGUAN PERTUMBUHAN PADA ANAK TALASEMIA MAYORGangguan pertumbuhan berupa perawakan pendek sering ditemukan pada penderita talasemia β mayor. Hal ini disebabkan oleh beberapa faktor seperti hipoksia, hemosiderosis, kekurangan asupan nutrisi, dan mikonutrien. Gangguan pertumbuhan akan memengaruhi kualitas hidup pasien. Penelitian ini bertujuan mengetahui prevalensi gangguan tumbuh kembang dan menganalisis faktor-faktor yang berhubungan dengan gangguan tumbuh kembang anak talasemia. Penelitian ini menggunakan jenis penelitian observasional analitik dengan desain cross-sectional pada 167 pasien talasemia β mayor di RS Palang Merah Indonesia, Bogor, Jawa Barat pada bulan Oktober–Desember 2018. Pengumpulan data dilakukan dengan menggunakan kuesioner kepatuhan transfusi dan Morisky Medication Adherence Scale (MMAS-8), sedangkan pertumbuhan dinilai menggunakan kurva tinggi/usia CDC 2000. Analisis data menggunakan SPSS for Windows versi 21.0. Dari 167 subjek, 86 subjek (51,5%) tidak patuh pada transfusi, 97 subjek (58,1%) memiliki konsumsi kelasi besi rendah, dan 146 subjek (87,4%) mengalami gangguan pertumbuhan. Hasil analisis data bivariat menggunakan uji chi-square untuk kepatuhan transfusi dan pendidikan orangtua tentang pertumbuhan diperoleh p=0,000 dan p=0,032. Begitu pula untuk kepatuhan konsumsi kelasi besi dan pendapatan orangtua terhadap pertumbuhan diperoleh p=0,000. Disimpulkan bahwa prevalensi gangguan tumbuh kembang sebesar 87,4% dan terdapat hubungan kepatuhan transfusi, tingkat pendidikan orangtua, pendapatan orangtua, dan kepatuhan konsumsi kelasi besi dengan gangguan tumbuh kembang anak talasemia.